TapewireFind a company

person · Reporting owner

Leal James

Disclosed activity across 1 company

Tapewire entity
90542
SEC CIK
0001866570

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
TANDEM DIABETES CARE INCTNDM · Entity 4682Chief Manufacturing OfficerMay 23, 2024May 28, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

TANDEM DIABETES CARE INC

Report date May 23, 2024 · Filed May 28, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect16,876 Ending reported balance After 2024-05-28 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2024-05-28 · Exercise / conversion · Acquired 310 · Balance 17,005

Row 2 · 2024-05-28 · Tax withholding · Disposed 129 · Balance 16,876

F1: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Restricted Stock UnitSEC Table II · derivative / convertible securityDirect16,257 Reported balance After 2024-05-23 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2024-05-23 · Grant · Acquired 16,257 · Balance 16,257

F2: Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).

F3: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

F4: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

Restricted Stock UnitSEC Table II · derivative / convertible securityDirect0 Reported balance After 2024-05-28 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2024-05-28 · Exercise / conversion · Disposed 310 · Balance 0

F5: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F6: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F7: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

F2: Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).

F3: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

F4: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

F5: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F6: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F7: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 15, 2023 Filed May 17, 2023 18:08 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 3,223 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000080 · wf-form4_168436130062849.xml · derivative · entry 7

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,446

Underlying: Common Stock · 3,223 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F5 · derivative.exercise_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 15, 2023 Filed May 17, 2023 18:08 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 168 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000080 · wf-form4_168436130062849.xml · derivative · entry 6

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,340

Underlying: Common Stock · 168 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F4 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 15, 2023 Filed May 17, 2023 18:08 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 1,333 $32.13 $42,829.29
Disclosure

SEC source: 0001438133-23-000080 · wf-form4_168436130062849.xml · nonDerivative · entry 5

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,415

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2023 Filed May 17, 2023 18:08 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 3,223 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000080 · wf-form4_168436130062849.xml · nonDerivative · entry 4

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,748

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 18:08 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 70 $32.13 $2,249.10
Disclosure

SEC source: 0001438133-23-000080 · wf-form4_168436130062849.xml · nonDerivative · entry 3

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,525

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2023 Filed May 17, 2023 18:08 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 168 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000080 · wf-form4_168436130062849.xml · nonDerivative · entry 2

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,595

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 18:08 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantCommon Stock 621 $27.32 $16,965.72
Disclosure

SEC source: 0001438133-23-000080 · wf-form4_168436130062849.xml · nonDerivative · entry 1

Leal James · CIK 0001866570 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,427

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 16, 2022 through May 15, 2023. This transaction is also exempt under Rule 16b-3(c).

Read SEC document
February 27, 2023 Filed Mar 1, 2023 18:22 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 310 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000042 · wf-form4_167771295289147.xml · derivative · entry 3

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,548

Underlying: Common Stock · 310 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 18:22 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 145 $35.87 $5,201.15
Disclosure

SEC source: 0001438133-23-000042 · wf-form4_167771295289147.xml · nonDerivative · entry 2

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,806

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 18:22 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 310 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000042 · wf-form4_167771295289147.xml · nonDerivative · entry 1

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,951

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 17:04 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 168 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000018 · wf-form4_167667142893122.xml · derivative · entry 3

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,508

Underlying: Common Stock · 168 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 17:04 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 79 $43.11 $3,405.69
Disclosure

SEC source: 0001438133-23-000018 · wf-form4_167667142893122.xml · nonDerivative · entry 2

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,641

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 17:04 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 168 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000018 · wf-form4_167667142893122.xml · nonDerivative · entry 1

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,720

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 28, 2022 Filed Nov 30, 2022 16:34 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 310 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000247 · wf-form4_166984407968174.xml · derivative · entry 3

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,858

Underlying: Common Stock · 310 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
November 28, 2022 Filed Nov 30, 2022 16:34 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 138 $39.54 $5,456.52
Disclosure

SEC source: 0001438133-22-000247 · wf-form4_166984407968174.xml · nonDerivative · entry 2

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,552

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 28, 2022 Filed Nov 30, 2022 16:34 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 310 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000247 · wf-form4_166984407968174.xml · nonDerivative · entry 1

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,690

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2022 Filed Nov 17, 2022 18:54 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 167 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000233 · wf-form4_166872927635731.xml · derivative · entry 3

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,676

Underlying: Common Stock · 167 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
November 15, 2022 Filed Nov 17, 2022 18:54 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 75 $42.27 $3,170.25
Disclosure

SEC source: 0001438133-22-000233 · wf-form4_166872927635731.xml · nonDerivative · entry 2

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,380

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 15, 2022 Filed Nov 17, 2022 18:54 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 167 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000233 · wf-form4_166872927635731.xml · nonDerivative · entry 1

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,455

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 29, 2022 Filed Aug 31, 2022 16:59 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 309 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000205 · wf-form4_166197956726665.xml · derivative · entry 3

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,168

Underlying: Common Stock · 309 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
August 29, 2022 Filed Aug 31, 2022 16:59 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 138 $46.68 $6,441.84
Disclosure

SEC source: 0001438133-22-000205 · wf-form4_166197956726665.xml · nonDerivative · entry 2

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,288

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
August 29, 2022 Filed Aug 31, 2022 16:59 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 309 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000205 · wf-form4_166197956726665.xml · nonDerivative · entry 1

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2022 Filed Aug 17, 2022 17:16 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 168 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000191 · wf-form4_166077096858644.xml · derivative · entry 3

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,843

Underlying: Common Stock · 168 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
August 15, 2022 Filed Aug 17, 2022 17:16 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 75 $55.25 $4,143.75
Disclosure

SEC source: 0001438133-22-000191 · wf-form4_166077096858644.xml · nonDerivative · entry 2

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,117

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
August 15, 2022 Filed Aug 17, 2022 17:16 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 168 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000191 · wf-form4_166077096858644.xml · nonDerivative · entry 1

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,192

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 27, 2022 Filed Jun 1, 2022 20:25 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 310 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000149 · wf-form4_165412952266536.xml · derivative · entry 3

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,477

Underlying: Common Stock · 310 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan ("the 2013 Plan").

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F4 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
May 27, 2022 Filed Jun 1, 2022 20:25 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 138 $70.81 $9,771.78
Disclosure

SEC source: 0001438133-22-000149 · wf-form4_165412952266536.xml · nonDerivative · entry 2

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,024

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 27, 2022 Filed Jun 1, 2022 20:25 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 310 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000149 · wf-form4_165412952266536.xml · nonDerivative · entry 1

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,162

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 25, 2022 Filed May 27, 2022 21:46 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantRestricted Stock Unit · Derivative 9,669 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000123 · wf-form4_165370236993451.xml · derivative · entry 2

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,669

Underlying: Common Stock · 9,669 shares

Expires not disclosed

F1 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 16, 2022 Filed May 18, 2022 19:20 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 670 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000085 · wf-form4_165291602211891.xml · derivative · entry 4

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,011

Underlying: Common Stock · 670 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company.

F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
May 16, 2022 Filed May 18, 2022 19:20 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantCommon Stock 310 $61.17 $18,962.70
Disclosure

SEC source: 0001438133-22-000085 · wf-form4_165291602211891.xml · nonDerivative · entry 3

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,852

F2 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 16, 2021 through May 16, 2022. This transaction is also exempt under Rule 16b-3(c).

Read SEC document
May 16, 2022 Filed May 18, 2022 19:20 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 298 $73.85 $22,007.30
Disclosure

SEC source: 0001438133-22-000085 · wf-form4_165291602211891.xml · nonDerivative · entry 2

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,542

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 16, 2022 Filed May 18, 2022 19:20 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 670 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000085 · wf-form4_165291602211891.xml · nonDerivative · entry 1

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,840

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 19:10 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 310 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000025 · wf-form4_164626619341736.xml · derivative · entry 3

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,787

Underlying: Common Stock · 310 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company.

F4 · derivative.exercise_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F4 · derivative.expiration_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 19:10 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 148 $112.43 $16,639.64
Disclosure

SEC source: 0001438133-22-000025 · wf-form4_164626619341736.xml · nonDerivative · entry 2

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,170

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold

Read SEC document
February 28, 2022 Filed Mar 2, 2022 19:10 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 310 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000025 · wf-form4_164626619341736.xml · nonDerivative · entry 1

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,318

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 27, 2021 Filed Dec 29, 2021 16:29 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionStock Option · Derivative 239 $82.34 Strike: $82.34 $19,679.26
Disclosure

SEC source: 0001438133-21-000232 · wf-form4_164081333996082.xml · derivative · entry 7

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,909

Underlying: Common Stock · 239 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the 2013 Plan.

F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
December 27, 2021 Filed Dec 29, 2021 16:29 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionStock Option · Derivative 1,667 $51.50 Strike: $51.50 $85,850.50
Disclosure

SEC source: 0001438133-21-000232 · wf-form4_164081333996082.xml · derivative · entry 6

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,333

Underlying: Common Stock · 1,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
December 27, 2021 Filed Dec 29, 2021 16:29 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 100 $152.27 $15,227.00
Disclosure

SEC source: 0001438133-21-000232 · wf-form4_164081333996082.xml · nonDerivative · entry 5

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,008

F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020.

Read SEC document
December 27, 2021 Filed Dec 29, 2021 16:29 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 1,266 $151.60 $191,925.60
Disclosure

SEC source: 0001438133-21-000232 · wf-form4_164081333996082.xml · nonDerivative · entry 4

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,108

F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020.

F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $151.26 to $152.09.The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
December 27, 2021 Filed Dec 29, 2021 16:29 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 540 $150.95 $81,513.00
Disclosure

SEC source: 0001438133-21-000232 · wf-form4_164081333996082.xml · nonDerivative · entry 3

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,374

F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020.

F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $150.25 to $151.21. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
December 27, 2021 Filed Dec 29, 2021 16:29 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 239 $82.34 $19,679.26
Disclosure

SEC source: 0001438133-21-000232 · wf-form4_164081333996082.xml · nonDerivative · entry 2

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,914

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares of common stock received upon exercise of a stock option award.

Read SEC document
December 27, 2021 Filed Dec 29, 2021 16:29 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 1,667 $51.50 $85,850.50
Disclosure

SEC source: 0001438133-21-000232 · wf-form4_164081333996082.xml · nonDerivative · entry 1

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,675

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares of common stock received upon exercise of a stock option award.

Read SEC document
November 29, 2021 Filed Dec 1, 2021 19:59 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionStock Option · Derivative 238 $82.34 Strike: $82.34 $19,596.92
Disclosure

SEC source: 0001438133-21-000226 · wf-form4_163840673830554.xml · derivative · entry 10

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,148

Underlying: Common Stock · 238 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the 2013 Plan.

F10 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
November 29, 2021 Filed Dec 1, 2021 19:59 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionStock Option · Derivative 1,667 $51.50 Strike: $51.50 $85,850.50
Disclosure

SEC source: 0001438133-21-000226 · wf-form4_163840673830554.xml · derivative · entry 9

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 1,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the 2013 Plan.

F10 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
November 29, 2021 Filed Dec 1, 2021 19:59 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 310 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000226 · wf-form4_163840673830554.xml · derivative · entry 8

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,097

Underlying: Common Stock · 310 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F7 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company.

F8 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F8 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
November 29, 2021 Filed Dec 1, 2021 19:59 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 5 $132.92 $664.60
Disclosure

SEC source: 0001438133-21-000226 · wf-form4_163840673830554.xml · nonDerivative · entry 7

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,008

F3 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020.

Read SEC document
November 29, 2021 Filed Dec 1, 2021 19:59 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 664 $131.54 $87,342.56
Disclosure

SEC source: 0001438133-21-000226 · wf-form4_163840673830554.xml · nonDerivative · entry 6

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,013

F3 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020.

F5 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $131.48 to $132.24.The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
November 29, 2021 Filed Dec 1, 2021 19:59 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 1,236 $130.64 $161,471.04
Disclosure

SEC source: 0001438133-21-000226 · wf-form4_163840673830554.xml · nonDerivative · entry 5

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,677

F3 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020.

F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $130.19 to $131.00. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
November 29, 2021 Filed Dec 1, 2021 19:59 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 238 $82.34 $19,596.92
Disclosure

SEC source: 0001438133-21-000226 · wf-form4_163840673830554.xml · nonDerivative · entry 4

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,913

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Represents shares of common stock received upon exercise of a stock option award.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.